Subscribe
shutterstock_1100040878_zyn_chakrapong
Zyn Chakrapong / Shutterstock.com
7 January 2021Big PharmaMuireann Bolger

MHRA unveils ‘innovation passport’ for new medicines

A licensing pathway that will reduce the time it takes for novel medicines to enter the marketplace has been launched by the UK Medicines and Healthcare products Regulatory Agency (MHRA).

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Europe
Counterfeit drug sites stung in MHRA operation
13 January 2015   UK regulatory body the Medicines and Healthcare and Products Regulatory Agency has successfully taken down more than 1,600 websites, some of which were selling counterfeit drugs.
Big Pharma
MHRA conducts operation into counterfeit medicines
16 May 2016   The UK government’s Medicines and Healthcare Products Regulatory Agency has conducted an operation into counterfeit and unlicensed erectile dysfunction medicines across London.


Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024

Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024
Americas
Big Pharma counsel embrace AI but data and legal risks loom
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024
Unified Patent Court
‘Every CMS filing is painful’: Notes from a Unified Patent Court dispute
26 September 2024
Unified Patent Court
Interview: Klaus Grabinski, UPC Court of Appeal president
24 September 2024
Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024

More on this story

Europe
Counterfeit drug sites stung in MHRA operation
13 January 2015   UK regulatory body the Medicines and Healthcare and Products Regulatory Agency has successfully taken down more than 1,600 websites, some of which were selling counterfeit drugs.
Big Pharma
MHRA conducts operation into counterfeit medicines
16 May 2016   The UK government’s Medicines and Healthcare Products Regulatory Agency has conducted an operation into counterfeit and unlicensed erectile dysfunction medicines across London.

More on this story

Europe
Counterfeit drug sites stung in MHRA operation
13 January 2015   UK regulatory body the Medicines and Healthcare and Products Regulatory Agency has successfully taken down more than 1,600 websites, some of which were selling counterfeit drugs.
Big Pharma
MHRA conducts operation into counterfeit medicines
16 May 2016   The UK government’s Medicines and Healthcare Products Regulatory Agency has conducted an operation into counterfeit and unlicensed erectile dysfunction medicines across London.

More features

Bayer gains exclusive licence for heart drug in Japan
EPO delivers key Novo Nordisk, GSK and Inhibrx rulings
McGuireWoods expands team with ex-Novo Nordisk GC
Paul, Weiss swoops for senior duo from Weil, Gotshal
UPC bans Meril Life Sciences from selling infringing heart valve
SCOTUS denies Alvogen unit's appeal to sell Bausch Xifaxan generic
Kathi Vidal to rejoin previous firm as partner following USPTO departure
GSK triumphs in EPO appeal, revoking Pfizer patent